Clinical features and perinatal outcomes in women with adenomyosis

Lu Liu, Liu L, Liu Lü, Zhang K, Kun Zhang, Xinran Gao, Gao X, Molin Wang, Wang M, Hongyan Guo, Guo H
European journal of obstetrics, gynecology, and reproductive biology · 2025 · vol. 313 , pp. 114631 · doi:10.1016/j.ejogrb.2025.114631 · PMID:40812191 · W4412999635
article OA: closed CC0
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-08 ⓘ

This study investigated the clinical characteristics and perinatal outcomes in women diagnosed with adenomyosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

OBJECTIVE: To analyze the correlation between Clinical Features and Perinatal Outcomes in the population of pregnancies with adenomyosis. METHODS: This retrospective study analyzed 413 pregnant women with ultrasonography/MRI-confirmed adenomyosis (diagnosed pre-pregnancy/early pregnancy) who delivered or miscarried at Peking University Third Hospital (2022-2024). Clinical features (dysmenorrhea, metrorrhagia, uterine volume, concurrent endometriosis) were evaluated for associations with delivery mode, gestational age, postpartum blood loss, premature rupture of membranes (PROM), operation time of cesarean section, placenta accreta, placenta previa, gestational hypertension. RESULTS: Multivariate analysis demonstrated that women with adenomyosis had significantly higher risks of infertility (OR = 3.540, 95 %CI [2.539-4.937], P < 0.001), pregnancy after assisted reproductive technology(ART) (OR = 2.739, 95 %CI [1.971-3.807], P < 0.001), preterm birth (OR = 2.132, 95 %CI [1.338-3.398], P < 0.001), placenta accreta (OR = 2.433, 95 %CI [1.289-4.593], P = 0.006), and placenta previa (OR = 3.117, 95 %CI [1.729-5.619], P < 0.001) compared to controls, along with longer postpartum hospitalization (β = 0.443, 95 %CI [0.232-0.655], P < 0.001), excessive postpartum hemorrhage(PPH) (OR = 47.956, 95 %CI [20.756-75.155], P < 0.001), and shorter gestation (β = -4.135, 95 %CI [-5.773--2.497], P < 0.001), while no significant differences were found in low birth weight babies(LBW) (OR = 1.586, 95 %CI [0.914-2.750], P = 0.101) or small for gestational age infant(SGA) (OR = 1.688, 95 %CI [0.942-3.026], P = 0.079). PPH correlated positively with uterine volume (β = 0.166, 95 %CI [0.235-1.550], P = 0.008) and age (β = 0.130, 95 %CI [0.669-19.497], P = 0.036), whereas gestational age showed negative correlation with uterine volume (β = -0.163, 95 %CI [-0.072--0.010], P = 0.009). Larger uterine volume increased LBW risk (OR = 1.010, 95 %CI [1.003-1.017], P = 0.007) but decreased SGA risk (OR = 0.984, 95 %CI [0.977-0.992], P < 0.001). Univariate analysis indicated higher LBW incidence when placenta implanted at adenomyosis lesions (P = 0.039). Diffuse adenomyosis exhibited stronger associations with ART (r = 0.355, 95 %CI [0.263-0.440], P < 0.001), LBW (r = 0.142, 95 %CI [0.041-0.240], P = 0.006), and preterm birth (r = 0.106, 95 %CI [0.004-0.205], P = 0.042), though these were nonsignificant in multivariate analysis, while demonstrating 3.963-fold higher cesarean risk (95 %CI [1.797-8.740], P < 0.001) versus focal adenomyosis. CONCLUSION: Adenomyosis is associated with an increased risk of a range of pregnancy complications such as infertility, preterm birth, LBW, SGA, placenta accreta, placenta previa and PPH. Moreover, uterine volume before pregnancy, adenomyosis subtypes, and the relative relationship between the placenta and the lesion also have an impact on perinatal outcome.

My notes (saved in your browser only)

Condition tags

adenomyosis

MeSH descriptors

Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (31)

Cited by (1)

Source provenance

europepmc
last seen: 2026-07-28T06:14:09.330459+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-07-28T06:09:53.445028+00:00
License: CC0 · commercial use OK